Acciones Acura Pharmaceuticals, Inc. Other OTC
Acciones
ACUR
US00509L8028
Biotecnología e investigación médica
Ventas 2020 | 3,57 M 3,34 M | Ventas 2021 | 1,56 M 1,46 M | Capitalización | 32,54 M 30,45 M |
---|---|---|---|---|---|
Resultado Neto 2020 | -1 M -936 mil | Resultado Neto 2021 | - 0 | VE / Ventas 2020 | 2,91 x |
Deuda neta 2020 | 5,86 M 5,48 M | Deuda neta 2021 | 135 mil 126 mil | VE / Ventas 2021 | 20,9 x |
P/E ratio 2020 |
-5,25
x | P/E ratio 2021 |
-25
x | Empleados | - |
Rendimiento 2020 * |
-
| Rendimiento 2021 |
-
| Flotante | 15,27 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 07/04/08 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01/02/98 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 01/03/98 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01/02/98 |
Bruce Wesson
BRD | Director/Board Member | 81 | 01/03/98 |
William Skelly
BRD | Director/Board Member | 73 | 01/05/96 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,45 % | 122 mil M | |
+21,96 % | 116 mil M | |
+25,68 % | 27,03 mil M | |
-20,05 % | 20,36 mil M | |
-16,28 % | 15,91 mil M | |
-15,94 % | 16,43 mil M | |
-44,35 % | 15,6 mil M | |
+63,91 % | 14,94 mil M | |
+2,52 % | 13,59 mil M |